Eagle Pharmaceuticals【EGRX】株式ニュース

名称	銘柄コード	市場	種別
Eagle Pharmaceuticals Inc	EGRX	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.0101	-0.25%	3.9899	22:34:33

始値	安値	高値	終値	前日終値
4.00	3.9891	4.00		4.00

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/5/29	21:20	EDGAR2	Form 8-K - Current report
2024/5/22	22:08	EDGAR2	Form 8-K - Current report
2024/5/15	22:29	EDGAR2	Form 8-K - Current report
2024/5/11	06:27	EDGAR2	Form NT 10-Q - Notification of inability to timely file Form..
2024/3/09	06:49	EDGAR2	Form 8-K - Current report
2024/3/02	06:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/01	21:35	EDGAR2	Form 8-K - Current report
2024/3/01	10:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/01	06:44	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/29	22:09	EDGAR2	Form 8-K - Current report
2024/2/15	07:09	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
2024/2/14	05:53	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/13	22:50	EDGAR2	Form 8-K - Current report
2024/2/09	19:45	PRNUS	Eagle Pharmaceuticals, Inc. Securities Fraud Class Action..
2024/2/07	23:15	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2024/2/07	07:09	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/02	19:45	PRNUS	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
2024/1/26	19:45	PRNUS	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
2024/1/19	19:45	PRNUS	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
2024/1/18	20:56	EDGAR2	Form 8-K - Current report
2024/1/18	20:50	GLOBE	Eagle Pharmaceuticals Provides Update on Bendamustine..
2024/1/16	21:00	EDGAR2	Form 8-K - Current report
2024/1/12	19:45	PRNUS	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
2024/1/10	07:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/10	07:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/05	19:45	PRNUS	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
2023/12/23	09:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/23	07:15	EDGAR2	Form 8-K/A - Current report: [Amend]
2023/12/21	06:34	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/18	19:45	PRNUS	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
2023/12/16	07:11	EDGAR2	Form 8-K - Current report
2023/12/07	06:26	EDGAR2	Form 8-K - Current report
2023/12/07	06:05	GLOBE	Eagle Pharmaceuticals to Present Abstract on Post-hoc..
2023/11/29	21:39	EDGAR2	Form 8-K - Current report
2023/11/29	21:36	EDGAR2	Form 8-K - Current report
2023/11/10	07:23	EDGAR2	Form NT 10-Q - Notification of inability to timely file Form..
2023/11/09	21:57	EDGAR2	Form 8-K - Current report
2023/11/09	21:30	GLOBE	Eagle Delays Third Quarter 2023 Results and Conference Call
2023/11/08	22:30	GLOBE	Eagle Pharmaceuticals to Host Third Quarter 2023 Financial..
2023/11/04	05:39	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/03	05:53	EDGAR2	Form 144 - Report of proposed sale of securities
2023/11/02	06:02	EDGAR2	Form 144 - Report of proposed sale of securities
2023/11/01	06:41	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/10/24	21:49	EDGAR2	Form 8-K - Current report
2023/10/24	21:40	GLOBE	Eagle Pharmaceuticals Granted Patent for PEMFEXY®
2023/10/23	20:10	EDGAR2	Form 8-K - Current report
2023/10/23	19:50	GLOBE	Eagle Pharmaceuticals Granted Unique J-Code and Pass-Through..
2023/10/05	06:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/10/04	19:50	GLOBE	Eagle Pharmaceuticals Awarded First Prize for Poster to Be..
2023/10/04	05:48	EDGAR2	Form 144 - Report of proposed sale of securities